Golgi fragmentation has been shown for ALS patients (Stieber et al., 1998) and SOD1 G93A transgenic fALS animal models (Mourelatos et al., 1996) by immunostaining for MG160, a Golgi-resident marker protein. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.